{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T17:16:45Z","timestamp":1764350205435,"version":"3.37.3"},"reference-count":192,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T00:00:00Z","timestamp":1412121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["R01 DA021550","R01 DA029512","R01 DA034086"],"award-info":[{"award-number":["R01 DA021550","R01 DA029512","R01 DA034086"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2014,10]]},"DOI":"10.1016\/j.antiviral.2014.07.015","type":"journal-article","created":{"date-parts":[[2014,8,7]],"date-time":"2014-08-07T12:46:56Z","timestamp":1407415616000},"page":"79-93","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"special_numbering":"C","title":["Can hepatitis C be eradicated in the United States?"],"prefix":"10.1016","volume":"110","author":[{"given":"Brian R.","family":"Edlin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emily R.","family":"Winkelstein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.antiviral.2014.07.015_b0005","doi-asserted-by":"crossref","first-page":"2878","DOI":"10.1007\/s10461-013-0593-y","article-title":"Effectiveness of structural-level needle\/syringe programs to reduce HCV and HIV infection among people who inject drugs: a systematic review","volume":"17","author":"Abdul-Quader","year":"2013","journal-title":"AIDS Behav."},{"issue":"Suppl. 2","key":"10.1016\/j.antiviral.2014.07.015_b0010","doi-asserted-by":"crossref","first-page":"S77","DOI":"10.1111\/j.1526-4637.2011.01128.x","article-title":"Project Lazarus: community-based overdose prevention in rural North Carolina","volume":"12","author":"Albert","year":"2011","journal-title":"Pain Med."},{"year":"2010","series-title":"The New Jim Crow: Mass Incarceration in the Age of Colorblindness","author":"Alexander","key":"10.1016\/j.antiviral.2014.07.015_b0015"},{"issue":"3","key":"10.1016\/j.antiviral.2014.07.015_b0020","doi-asserted-by":"crossref","first-page":"187","DOI":"10.7326\/0003-4819-138-3-200302040-00010","article-title":"Treatment of chronic hepatitis C in a state correctional facility","volume":"138","author":"Allen","year":"2003","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.antiviral.2014.07.015_b0025","unstructured":"American Medical Association, 2001. Principles of Medical Ethics. Accessed at <http:\/\/www.ama-assn.org\/ama\/pub\/physician-resources\/medical-ethics\/code-medical-ethics\/principles-medical-ethics.page> on 8 January 2014."},{"year":"2013","series-title":"Syringe Exchange Program Coverage in the United States \u2013July 2013","author":"amfAR Foundation for AIDS Research","key":"10.1016\/j.antiviral.2014.07.015_b0030"},{"issue":"3","key":"10.1016\/j.antiviral.2014.07.015_b0035","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1177\/016059769602000304","article-title":"Social setting, stigma management, and recovering drug addicts","volume":"20","author":"Anderson","year":"1996","journal-title":"Humanit. Soc."},{"issue":"10","key":"10.1016\/j.antiviral.2014.07.015_b0040","doi-asserted-by":"crossref","first-page":"705","DOI":"10.7326\/0003-4819-144-10-200605160-00004","article-title":"The prevalence of hepatitis C virus infection in the United States, 1999 through 2002","volume":"144","author":"Armstrong","year":"2006","journal-title":"Ann. Intern. Med."},{"issue":"Suppl. 2","key":"10.1016\/j.antiviral.2014.07.015_b0045","doi-asserted-by":"crossref","first-page":"S80","DOI":"10.1093\/cid\/cit306","article-title":"Treatment of hepatitis C virus infection among people who are actively injecting drugs: a systematic review and meta-analysis","volume":"57","author":"Aspinall","year":"2013","journal-title":"Clin. Infect. Dis."},{"issue":"11","key":"10.1016\/j.antiviral.2014.07.015_b0050","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/S1473-3099(12)70177-9","article-title":"Prevalence of tuberculosis, hepatitis C virus, and HIV in homeless people: a systematic review and meta-analysis","volume":"12","author":"Beijer","year":"2012","journal-title":"Lancet Infect. Dis."},{"issue":"2","key":"10.1016\/j.antiviral.2014.07.015_b0055","doi-asserted-by":"crossref","first-page":"231","DOI":"10.2105\/AJPH.2006.103747","article-title":"The law (and politics) of safe injection facilities in the United States","volume":"98","author":"Beletsky","year":"2008","journal-title":"Am. J. Public Health"},{"issue":"2","key":"10.1016\/j.antiviral.2014.07.015_b0060","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1111\/j.1360-0443.2010.03149.x","article-title":"The roles of law, client race and program visibility in shaping police interference with the operation of US syringe exchange programs","volume":"106","author":"Beletsky","year":"2011","journal-title":"Addiction"},{"issue":"11","key":"10.1016\/j.antiviral.2014.07.015_b0065","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.2105\/AJPH.2011.300254","article-title":"Police training to align law enforcement and HIV prevention: preliminary evidence from the field","volume":"101","author":"Beletsky","year":"2011","journal-title":"Am. J. Public Health"},{"issue":"1","key":"10.1016\/j.antiviral.2014.07.015_b0070","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.drugpo.2013.06.005","article-title":"Syringe access, syringe sharing, and police encounters among people who inject drugs in New York City: a community-level perspective","volume":"25","author":"Beletsky","year":"2014","journal-title":"Int. J. Drug Policy"},{"issue":"9737","key":"10.1016\/j.antiviral.2014.07.015_b0075","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/S0140-6736(10)61005-7","article-title":"12 myths about HIV\/AIDS and people who use drugs","volume":"376","author":"Beyrer","year":"2010","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.antiviral.2014.07.015_b0080","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.drugpo.2007.01.013","article-title":"Integrating multiple programme and policy approaches to hepatitis C prevention and care for injection drug users: a comprehensive approach","volume":"18","author":"Birkhead","year":"2007","journal-title":"Int. J. Drug Policy"},{"issue":"9650","key":"10.1016\/j.antiviral.2014.07.015_b0085","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1016\/S0140-6736(08)61693-1","article-title":"Addressing social determinants of health inequities: what can the state and civil society do?","volume":"372","author":"Blas","year":"2008","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.antiviral.2014.07.015_b0090","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.amjmed.2012.11.031","article-title":"Reducing the health consequences of opioid addiction in primary care","volume":"126","author":"Bowman","year":"2013","journal-title":"Am. J. Med."},{"year":"2004","series-title":"Doing Time on the Outside: Incarceration and Family Life in Urban America","author":"Braman","key":"10.1016\/j.antiviral.2014.07.015_b0095"},{"issue":"3","key":"10.1016\/j.antiviral.2014.07.015_b0100","first-page":"259","article-title":"Project Lazarus: an innovative community response to prescription drug overdose","volume":"74","author":"Brason","year":"2013","journal-title":"N. C. Med. J."},{"issue":"617","key":"10.1016\/j.antiviral.2014.07.015_b0105","doi-asserted-by":"crossref","first-page":"842","DOI":"10.3399\/bjgp13X675421","article-title":"Can antiviral treatment for hepatitis C be safely and effectively delivered in primary care?","volume":"63","author":"Brew","year":"2013","journal-title":"Br. J. Gen. Pract."},{"issue":"Suppl. 2","key":"10.1016\/j.antiviral.2014.07.015_b0110","doi-asserted-by":"crossref","first-page":"S56","DOI":"10.1093\/cid\/cit271","article-title":"Models of care for the management of hepatitis C virus among people who inject drugs: one size does not fit all","volume":"57","author":"Bruggmann","year":"2013","journal-title":"Clin. Infect. Dis."},{"issue":"6 Suppl. 2","key":"10.1016\/j.antiviral.2014.07.015_b0115","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1331\/1086-5802.42.0.S13.Burris","article-title":"The legality of selling or giving syringes to injection drug users","volume":"42","author":"Burris","year":"2002","journal-title":"J. Am. Pharm. Assoc. (Wash.)"},{"issue":"12","key":"10.1016\/j.antiviral.2014.07.015_b0120","doi-asserted-by":"crossref","first-page":"858","DOI":"10.7326\/M14-0216","article-title":"Reducing firearm-related injuries and deaths in the United States: executive summary of a policy position paper from the American College of Physicians","volume":"160","author":"Butkus","year":"2014","journal-title":"Ann. Intern. Med."},{"year":"2010","series-title":"Establishing a Holistic Framework to Reduce Inequities in HIV, viral hepatitis, STDs, and Tuberculosis in the United States: An NCHHSTP White Paper on Social Determinants of Health","author":"Centers for Disease Control and Prevention","key":"10.1016\/j.antiviral.2014.07.015_b0125"},{"year":"2013","series-title":"Viral Hepatitis Surveillance, United States, 2011","author":"Centers for Disease Control and Prevention","key":"10.1016\/j.antiviral.2014.07.015_b0130"},{"issue":"RR-5","key":"10.1016\/j.antiviral.2014.07.015_b0705","first-page":"1","article-title":"Integrated prevention services for HIV infection, viral hepatitis, sexually transmitted diseases, and tuberculosis for persons who use drugs illicitly: summary guidance from CDC and the U.S. Department of Health and Human Services","volume":"61","author":"Centers for Disease Control and Prevention","year":"2012","journal-title":"MMWR Recomm. Rep."},{"issue":"11","key":"10.1016\/j.antiviral.2014.07.015_b0135","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1016\/j.cgh.2013.05.014","article-title":"Cost effectiveness of direct-acting antiviral therapy for treatment-naive patients with chronic HCV genotype 1 infection in the veterans health administration","volume":"11","author":"Chan","year":"2013","journal-title":"Clin. Gastroenterol. Hepatol."},{"year":"2007","series-title":"Imprisoning Communities: How Mass Incarceration Makes Disadvantaged Neighborhoods Worse","author":"Clear","key":"10.1016\/j.antiviral.2014.07.015_b0140"},{"key":"10.1016\/j.antiviral.2014.07.015_b0145","series-title":"Disease Eradication in the 21st Century: Implications for Global Health","first-page":"1","article-title":"The eradication of infectious diseases: understanding the lessons and advancing experience","author":"Cochi","year":"2011"},{"issue":"Suppl. 1","key":"10.1016\/j.antiviral.2014.07.015_b0150","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1177\/00333549141291S102","article-title":"Screening for hepatitis C as a prevention enhancement (SHAPE) for HIV: an integration pilot initiative in a Massachusetts county correctional facility","volume":"129","author":"Cocoros","year":"2014","journal-title":"Public Health Rep."},{"issue":"3","key":"10.1016\/j.antiviral.2014.07.015_b0155","doi-asserted-by":"crossref","first-page":"207","DOI":"10.7326\/M13-2781","article-title":"The dueling obligations of opioid stewardship","volume":"160","author":"Coffin","year":"2014","journal-title":"Ann. Intern. Med."},{"issue":"9","key":"10.1016\/j.antiviral.2014.07.015_b0160","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1093\/cid\/cis011","article-title":"Cost-effectiveness and population outcomes of general population screening for hepatitis C","volume":"54","author":"Coffin","year":"2012","journal-title":"Clin. Infect. Dis."},{"issue":"2\u20133","key":"10.1016\/j.antiviral.2014.07.015_b0165","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1080\/10826080601141982","article-title":"Drug courts \u2013 just the beginning: getting other areas of public policy in sync","volume":"42","author":"Cooper","year":"2007","journal-title":"Subst. Use Misuse"},{"key":"10.1016\/j.antiviral.2014.07.015_b0170","unstructured":"Costa, A.M., 2008. Making drug control \u201cfit for purpose\u201d: Building on the UNGASS decade. Report by the Executive Director of the United Nations Office on Drugs and Crime. E\/CN.7\/2008\/CRP.17. United Nations Office on Drugs and Crime, Vienna. Accessed at <http:\/\/www.unodc.org\/documents\/commissions\/CND-Session51\/CND-UNGASS-CRPs\/ECN72008CRP17.pdf> on 9 January 2014."},{"key":"10.1016\/j.antiviral.2014.07.015_b0175","unstructured":"Count the Costs, 2013. The War on Drugs: Wasting Billions, Undermining Economies. Accessed at <http:\/\/www.countthecosts.org\/seven-costs\/wasting-billions-drug-law-enforcement> on 6 January 2014."},{"issue":"Suppl. 2","key":"10.1016\/j.antiviral.2014.07.015_b0180","doi-asserted-by":"crossref","first-page":"S75","DOI":"10.1093\/cid\/cit297","article-title":"Peer support models for people with a history of injecting drug use undertaking assessment and treatment for hepatitis C virus infection","volume":"57","author":"Crawford","year":"2013","journal-title":"Clin. Infect. Dis."},{"issue":"9","key":"10.1016\/j.antiviral.2014.07.015_b0185","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.2105\/AJPH.2012.301178","article-title":"Randomized, community-based pharmacy intervention to expand services beyond sale of sterile syringes to injection drug users in pharmacies in New York City","volume":"103","author":"Crawford","year":"2013","journal-title":"Am. J. Public Health"},{"issue":"9737","key":"10.1016\/j.antiviral.2014.07.015_b0190","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S0140-6736(10)60742-8","article-title":"Prevention of HIV infection for people who inject drugs: why individual, structural, and combination approaches are needed","volume":"376","author":"Degenhardt","year":"2010","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.antiviral.2014.07.015_b0195","doi-asserted-by":"crossref","first-page":"293","DOI":"10.7326\/M13-1133","article-title":"Chronic hepatitis C virus infection in the United States, National Health and Nutrition Examination Survey 2003 to 2010","volume":"160","author":"Denniston","year":"2014","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.antiviral.2014.07.015_b0200","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1093\/infdis\/jis677","article-title":"Transmission of Hepatitis C virus among people who inject drugs: viral stability and association with drug preparation equipment","volume":"207","author":"Doerrbecker","year":"2013","journal-title":"J. Infect. Dis."},{"issue":"25","key":"10.1016\/j.antiviral.2014.07.015_b0205","doi-asserted-by":"crossref","first-page":"2374","DOI":"10.1056\/NEJMp1310121","article-title":"Housing as health care\u2013New York\u2019s boundary-crossing experiment","volume":"369","author":"Doran","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.antiviral.2014.07.015_b0210","series-title":"Vaccines: Preventing Disease & Protecting Health","first-page":"354","article-title":"Perspectives for the elimination\/eradication of diseases with vaccines","author":"Dowdle","year":"2004"},{"issue":"Suppl. 4","key":"10.1016\/j.antiviral.2014.07.015_b0215","doi-asserted-by":"crossref","first-page":"D70","DOI":"10.1016\/j.vaccine.2011.04.006","article-title":"The principles and feasibility of disease eradication","volume":"29","author":"Dowdle","year":"2011","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.antiviral.2014.07.015_b0220","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1521\/aeap.17.1.68.58688","article-title":"What\u2019s community got to do with it? Implementation models of syringe exchange programs","volume":"17","author":"Downing","year":"2005","journal-title":"AIDS Educ. Prev."},{"year":"2011","series-title":"A Plague of Prisons: The Epidemiology of Mass Incarceration in America","author":"Drucker","key":"10.1016\/j.antiviral.2014.07.015_b0225"},{"year":"2011","series-title":"Drug Courts are Not the Answer: Toward a Health-Centered Approach to Drug Use","author":"Drug Policy Alliance","key":"10.1016\/j.antiviral.2014.07.015_b0230"},{"year":"1970","series-title":"The Legislation of Morality: Law, Drugs, and Moral Judgment","author":"Duster","key":"10.1016\/j.antiviral.2014.07.015_b0235"},{"issue":"9925","key":"10.1016\/j.antiviral.2014.07.015_b0240","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1016\/S0140-6736(14)60630-9","article-title":"A new direction for hepatitis C","volume":"383","author":"Editorial","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.antiviral.2014.07.015_b0245","unstructured":"Editorial Board. Budget Grief for the Poor and Jobless. New York Times 2013 November 2:A22. Accessed at <http:\/\/www.nytimes.com\/2013\/11\/02\/opinion\/budget-grief-for-the-poor-and-jobless.html> on 8 January 2014."},{"key":"10.1016\/j.antiviral.2014.07.015_b0250","unstructured":"Editorial Board. More Hunger for the Poorest Americans. New York Times 2013 December 25:A26. Accessed at <http:\/\/www.nytimes.com\/2013\/12\/25\/opinion\/more-hunger-for-the-poorest-americans.html> on 8 January 2014."},{"key":"10.1016\/j.antiviral.2014.07.015_b0255","unstructured":"Editorial Board. End mass incarceration now. New York Times 2014 May 24:SR10."},{"issue":"4 Suppl. 1","key":"10.1016\/j.antiviral.2014.07.015_b0260","first-page":"213A","article-title":"Five million Americans infected with the hepatitis C virus: a corrected estimate","volume":"42","author":"Edlin","year":"2005","journal-title":"Hepatology"},{"issue":"7350","key":"10.1016\/j.antiviral.2014.07.015_b0265","doi-asserted-by":"crossref","first-page":"S18","DOI":"10.1038\/474S18a","article-title":"Perspective: test and treat this silent killer","volume":"474","author":"Edlin","year":"2011","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.antiviral.2014.07.015_b0270","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1002\/hep.26194","article-title":"Hepatitis C screening: getting it right","volume":"57","author":"Edlin","year":"2013","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.antiviral.2014.07.015_b0275","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1086\/499960","article-title":"Injection drug users: the overlooked core of the hepatitis C epidemic","volume":"42","author":"Edlin","year":"2006","journal-title":"Clin. Infect. Dis."},{"issue":"2","key":"10.1016\/j.antiviral.2014.07.015_b0280","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1007\/s11901-007-0005-8","article-title":"Managing hepatitis C in users of illicit drugs","volume":"6","author":"Edlin","year":"2007","journal-title":"Curr. Hepat. Rep."},{"year":"2013","series-title":"To Repair the World: Paul Farmer Speaks to the Next Generation","author":"Farmer","key":"10.1016\/j.antiviral.2014.07.015_b0285"},{"issue":"25","key":"10.1016\/j.antiviral.2014.07.015_b0290","doi-asserted-by":"crossref","first-page":"2424","DOI":"10.1056\/NEJMsa1310472","article-title":"Shattuck Lecture. Chronic infectious disease and the future of health care delivery","volume":"369","author":"Farmer","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.antiviral.2014.07.015_b0295","first-page":"CD003410","article-title":"Heroin maintenance for chronic heroin-dependent individuals","volume":"12","author":"Ferri","year":"2011","journal-title":"Cochrane Database Syst. Rev."},{"issue":"4","key":"10.1016\/j.antiviral.2014.07.015_b0300","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.drugpo.2005.06.010","article-title":"Policing as public health menace in the policy struggles over public injecting","volume":"16","author":"Fitzgerald","year":"2005","journal-title":"Int. J. Drug Policy"},{"key":"10.1016\/j.antiviral.2014.07.015_b0305","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1186\/1472-6963-10-92","article-title":"\u2018Reaching the hard to reach\u2019\u2013lessons learned from the VCS (voluntary and community sector). A qualitative study","volume":"10","author":"Flanagan","year":"2010","journal-title":"BMC Health Serv. Res."},{"issue":"2","key":"10.1016\/j.antiviral.2014.07.015_b0310","doi-asserted-by":"crossref","first-page":"344","DOI":"10.2105\/AJPH.2010.191759","article-title":"Drug arrests and injection drug deterrence","volume":"101","author":"Friedman","year":"2011","journal-title":"Am. J. Public Health"},{"issue":"1","key":"10.1016\/j.antiviral.2014.07.015_b0315","doi-asserted-by":"crossref","first-page":"117","DOI":"10.2105\/AJPH.2005.069591","article-title":"Multilevel community-based intervention to increase access to sterile syringes among injection drug users through pharmacy sales in New York City","volume":"97","author":"Fuller","year":"2007","journal-title":"Am. J. Public Health"},{"issue":"5","key":"10.1016\/j.antiviral.2014.07.015_b0320","doi-asserted-by":"crossref","first-page":"655","DOI":"10.2105\/AJPH.86.5.655","article-title":"Viral infections in short-term injection drug users: the prevalence of the hepatitis C, hepatitis B, human immunodeficiency, and human T-lymphotropic viruses","volume":"86","author":"Garfein","year":"1996","journal-title":"Am. J. Public Health"},{"issue":"Suppl. 1","key":"10.1016\/j.antiviral.2014.07.015_b0325","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1097\/00042560-199802001-00004","article-title":"Prevalence and incidence of hepatitis C virus infection among young adult injection drug users","volume":"18","author":"Garfein","year":"1998","journal-title":"J. Acquir. Immune Defic. Syndr. Hum. Retrovirol."},{"issue":"4","key":"10.1016\/j.antiviral.2014.07.015_b0330","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1177\/003335491212700409","article-title":"Prevalence, distribution, and correlates of hepatitis C virus infection among homeless adults in Los Angeles","volume":"127","author":"Gelberg","year":"2012","journal-title":"Public Health Rep."},{"year":"1990","series-title":"Treating Drug Problems","key":"10.1016\/j.antiviral.2014.07.015_b0335"},{"key":"10.1016\/j.antiviral.2014.07.015_b0340","unstructured":"Global Commission on Drug Policy, 2011. War on Drugs: Report of the Global Commission on Drug Policy: Global Commission on Drug Policy. Accessed at <http:\/\/www.globalcommissionondrugs.org\/reports\/> on 9 January 2014."},{"key":"10.1016\/j.antiviral.2014.07.015_b0345","unstructured":"Global Commission on Drug Policy, 2012. The War on Drugs and HIV\/AIDS: How the Criminalization of drug Use Fuels the Global Pandemic: Global Commission on Drug Policy. Accessed at <http:\/\/www.globalcommissionondrugs.org\/hivaids-pandemic\/> on 9 January 2014."},{"key":"10.1016\/j.antiviral.2014.07.015_b0350","unstructured":"Global Commission on Drug Policy, 2013. The Negative Impact of the War on Drugs on Public Health: The Hidden Hepatitis C Epidemic: Global Commission on Drug Policy. Accessed at <http:\/\/www.globalcommissionondrugs.org\/hepatitis\/> on 9 January 2014."},{"year":"1963","series-title":"Stigma; notes on the management of spoiled identity","author":"Goffman","key":"10.1016\/j.antiviral.2014.07.015_b0355"},{"year":"2014","series-title":"On the Run: Fugitive Life in an American City","author":"Goffman","key":"10.1016\/j.antiviral.2014.07.015_b0360"},{"issue":"1","key":"10.1016\/j.antiviral.2014.07.015_b0365","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1001\/jama.1997.03540250061033","article-title":"Prevention of HIV\/AIDS and other blood-borne diseases among injection drug users. A national survey on the regulation of syringes and needles","volume":"277","author":"Gostin","year":"1997","journal-title":"JAMA"},{"key":"10.1016\/j.antiviral.2014.07.015_b0370","first-page":"CD004145","article-title":"Oral substitution treatment of injecting opioid users for prevention of HIV infection","volume":"8","author":"Gowing","year":"2011","journal-title":"Cochrane Database Syst. Rev."},{"issue":"6","key":"10.1016\/j.antiviral.2014.07.015_b0375","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1002\/hep.21762","article-title":"Advocacy: what is a nice scientist like you doing in Washington, DC?","volume":"45","author":"Grace","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.antiviral.2014.07.015_b0380","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.antiviral.2014.01.002","article-title":"Can hepatitis C virus infection be eradicated in people who inject drugs?","volume":"104","author":"Grebely","year":"2014","journal-title":"Antiviral Res."},{"key":"10.1016\/j.antiviral.2014.07.015_b0385","doi-asserted-by":"crossref","unstructured":"Greenwald, G., 2009. Drug Decriminalization in Portugal: Lessons for Creating Fair and Successful Drug Policies. Cato Institute, Washington, D.C., Accessed at <http:\/\/www.cato.org\/publications\/white-paper\/drug-decriminalization-portugal-lessons-creating-fair-successful-drug-policies> on 9 January 2014.","DOI":"10.2139\/ssrn.1464837"},{"key":"10.1016\/j.antiviral.2014.07.015_b0390","unstructured":"Grover, A., 2010. Report of the Special Rapporteur on the right of everyone to the enjoyment of the highest attainable standard of physical and mental health. A\/65\/255: Sixty-fifth session of the United Nations General Assembly. Accessed at <http:\/\/daccess-dds-ny.un.org\/doc\/UNDOC\/GEN\/N10\/477\/91\/PDF\/N1047791.pdf> on 28 January 2014."},{"issue":"20","key":"10.1016\/j.antiviral.2014.07.015_b0395","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.1001\/jama.296.20.2467","article-title":"Public roles of US physicians: community participation, political involvement, and collective advocacy","volume":"296","author":"Gruen","year":"2006","journal-title":"JAMA"},{"issue":"9585","key":"10.1016\/j.antiviral.2014.07.015_b0400","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/S0140-6736(07)61200-8","article-title":"History, principles, and practice of health and human rights","volume":"370","author":"Gruskin","year":"2007","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.antiviral.2014.07.015_b0405","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1093\/oxfordjournals.aje.a009792","article-title":"Syringe exchange and risk of infection with hepatitis B and C viruses","volume":"149","author":"Hagan","year":"1999","journal-title":"Am. J. Epidemiol."},{"issue":"1","key":"10.1016\/j.antiviral.2014.07.015_b0410","doi-asserted-by":"crossref","first-page":"42","DOI":"10.2105\/AJPH.91.1.42","article-title":"Sharing of drug preparation equipment as a risk factor for hepatitis C","volume":"91","author":"Hagan","year":"2001","journal-title":"Am. J. Public Health"},{"issue":"1","key":"10.1016\/j.antiviral.2014.07.015_b0415","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1093\/infdis\/jir196","article-title":"A systematic review and meta-analysis of interventions to prevent hepatitis C virus infection in people who inject drugs","volume":"204","author":"Hagan","year":"2011","journal-title":"J. Infect. Dis."},{"issue":"11","key":"10.1016\/j.antiviral.2014.07.015_b0420","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1086\/345554","article-title":"Hepatitis C virus seroconversion among young injection drug users: relationships and risks","volume":"186","author":"Hahn","year":"2002","journal-title":"J. Infect. Dis."},{"issue":"11","key":"10.1016\/j.antiviral.2014.07.015_b0425","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.2105\/AJPH.92.11.1789","article-title":"The burden of infectious disease among inmates of and releasees from US correctional facilities, 1997","volume":"92","author":"Hammett","year":"2002","journal-title":"Am. J. Public Health"},{"year":"2011","series-title":"Raising the Profile, Raising Your Voice: A Primer on Viral Hepatitis Policymaking and Programs at the Federal Level","author":"Hanen","key":"10.1016\/j.antiviral.2014.07.015_b0430"},{"year":"2012","series-title":"Barriers and Facilitators to Hepatitis C Treatment for People Who Inject Drugs: A Qualitative Study","author":"Harris","key":"10.1016\/j.antiviral.2014.07.015_b0435"},{"key":"10.1016\/j.antiviral.2014.07.015_b0440","unstructured":"Hedrich, D., Kerr, T., Dubois-Arber, F., 2010. Chapter 11: drug consumption facilities in Europe and beyond. In: Rhodes, T., Dagmar, H. (Eds.), Harm Reduction: Evidence, Impacts, and Challenges. EMCDDA Monograph No. 10. European Monitoring Centre for Drugs and Drug Addiction, Luxembourg, pp. 305\u2013331. Accessed at <http:\/\/www.emcdda.europa.eu\/publications\/monographs\/harm-reduction> on 28 January 2014."},{"issue":"2","key":"10.1016\/j.antiviral.2014.07.015_b0445","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1002\/hep.26623","article-title":"Eradication of hepatitis C infection: the importance of targeting people who inject drugs","volume":"59","author":"Hellard","year":"2014","journal-title":"Hepatology"},{"issue":"7","key":"10.1016\/j.antiviral.2014.07.015_b0450","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1093\/cid\/ciu012","article-title":"Minimum costs for producing hepatitis C direct-acting antivirals for use in large-scale treatment access programs in developing countries","volume":"58","author":"Hill","year":"2014","journal-title":"Clin. Infect. Dis."},{"issue":"1","key":"10.1016\/j.antiviral.2014.07.015_b0455","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1056\/NEJMra1200391","article-title":"Disease eradication","volume":"368","author":"Hopkins","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.antiviral.2014.07.015_b0460","unstructured":"Hunt, N., Albert, E., S\u00e1nchez, V.M., 2010. Chapter 12: user involvement and user organising in harm reduction. In: Rhodes, T., Dagmar, H. (Eds.), Harm Reduction: Evidence, Impacts and Challenges. EMCDDA Monograph 10. European Monitoring Centre for Drugs and Drug Addiction, Luxembourg, pp. 333\u2013354. Accessed at <http:\/\/www.emcdda.europa.eu\/publications\/monographs\/harm-reduction> on 28 January 2014."},{"key":"10.1016\/j.antiviral.2014.07.015_b0465","unstructured":"Hutchinson, S., 2013. Translating research into public health policy: the Scottish National Hepatitis C Action Plan. Third International Symposium on Hepatitis Care in Substance Users, Munich, Germany, 5\u20136 September 2013, Suchtmed 15(4):217. Accessed at <http:\/\/www.inhsu.com\/symposium2013\/thursday-5-september-presentations\/> on 3 February 2014."},{"key":"10.1016\/j.antiviral.2014.07.015_b0470","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1186\/1471-2334-13-374","article-title":"HCV infected prisoners: should they be still considered a difficult to treat population?","volume":"13","author":"Iacomi","year":"2013","journal-title":"BMC Infect. Dis."},{"year":"2006","series-title":"Improving the Quality of Health Care for Mental and Substance-Use Conditions","author":"Institute of Medicine","key":"10.1016\/j.antiviral.2014.07.015_b0475"},{"year":"2010","series-title":"Hepatitis and Liver Cancer: A National Strategy for Prevention and Control of Hepatitis B and C","author":"Institute of Medicine","key":"10.1016\/j.antiviral.2014.07.015_b0480"},{"year":"2013","series-title":"Partnering with Patients to Drive Shared Decisions, Better Value, and Care Improvement","author":"Institute of Medicine","key":"10.1016\/j.antiviral.2014.07.015_b0485"},{"year":"2013","series-title":"The Drug Problem in the Americas","author":"Insulza","key":"10.1016\/j.antiviral.2014.07.015_b0490"},{"key":"10.1016\/j.antiviral.2014.07.015_b0495","unstructured":"International Network of People Who Use Drugs, 2008. Nothing about us without us. A Manifesto by People Who Use Illegal Drugs. International HIV\/AIDS Alliance, Canadian HIV\/AIDS Legal Network, Open Society Institute, International Network of People Who Use Drugs, International ed. Accessed at <http:\/\/www.aidsalliance.org\/publicationsdetails.aspx?id=310> on 20 March 2014."},{"key":"10.1016\/j.antiviral.2014.07.015_b0500","unstructured":"J\u00fcrgens, R., 2008. \u201cNothing about us without us\u201d \u2013 Greater, Meaningful Involvement of People Who Use Illegal Drugs: A Public Health, Ethical, and Human Rights Imperative. International HIV\/AIDS Alliance, Canadian HIV\/AIDS Legal Network, Open Society Institute, International ed., Toronto. Accessed at <http:\/\/www.aidsalliance.org\/publicationsdetails.aspx?id=310> on 20 March 2014."},{"issue":"9739","key":"10.1016\/j.antiviral.2014.07.015_b0505","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/S0140-6736(10)60830-6","article-title":"People who use drugs, HIV, and human rights","volume":"376","author":"Jurgens","year":"2010","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.antiviral.2014.07.015_b0510","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.drugpo.2005.04.005","article-title":"The public health and social impacts of drug market enforcement: a review of the evidence","volume":"16","author":"Kerr","year":"2005","journal-title":"Int. J. Drug Policy"},{"issue":"Suppl. 2","key":"10.1016\/j.antiviral.2014.07.015_b0515","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1177\/00333549071220S216","article-title":"Promoting HCV treatment completion for prison inmates: New York State\u2019s hepatitis C continuity program","volume":"122","author":"Klein","year":"2007","journal-title":"Public Health Rep."},{"key":"10.1016\/j.antiviral.2014.07.015_b0520","unstructured":"Kohli, A., Sims, Z., Nelson, A., Osinusi, A., Teferi, G., Pang, P., Symonds, W.T., McHutchison, J., Masur, H., Kottilil, S., 2014. Combination oral, hepatitis C antiviral therapy for 6 or 12 weeks: final results from the NIAID SYNERGY trial [abstract 27LB]. In: Conference on Retroviruses and Opportunistic Infections, Boston, Massachusetts, 3\u20136 March 2014: Program and Abstracts. International Antiviral Society\u2013USA, San Francisco, pp. 102\u2013103."},{"issue":"10","key":"10.1016\/j.antiviral.2014.07.015_b0525","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1093\/aje\/kwg070","article-title":"Trends in human immunodeficiency virus seroincidence among street-recruited injection drug users in San Francisco, 1987\u20131998","volume":"157","author":"Kral","year":"2003","journal-title":"Am. J. Epidemiol."},{"issue":"2","key":"10.1016\/j.antiviral.2014.07.015_b0530","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.jhep.2011.05.032","article-title":"Gaps in the achievement of effectiveness of HCV treatment in national VA practice","volume":"56","author":"Kramer","year":"2012","journal-title":"J. Hepatol."},{"issue":"4","key":"10.1016\/j.antiviral.2014.07.015_b0535","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1097\/QAI.0b013e3181a2539a","article-title":"The impact of needle and syringe programs on HIV and HCV transmissions in injecting drug users in Australia: a model-based analysis","volume":"51","author":"Kwon","year":"2009","journal-title":"J. Acquir. Immune Defic. Syndr."},{"issue":"1","key":"10.1016\/j.antiviral.2014.07.015_b0540","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1002\/emmm.201303131","article-title":"Emerging therapies for the treatment of hepatitis C","volume":"6","author":"Lange","year":"2014","journal-title":"EMBO Mol. Med."},{"issue":"4","key":"10.1016\/j.antiviral.2014.07.015_b0545","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1002\/hep.26387","article-title":"Incidence and prevalence of hepatitis C in prisons and other closed settings: results of a systematic review and meta-analysis","volume":"58","author":"Larney","year":"2013","journal-title":"Hepatology"},{"year":"2011","series-title":"Hepatitis C Among People Who Use Drugs: Key Messages from Practitioners","author":"Leicht","key":"10.1016\/j.antiviral.2014.07.015_b0550"},{"key":"10.1016\/j.antiviral.2014.07.015_b0555","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1146\/annurev.soc.27.1.363","article-title":"Conceptualizing stigma","volume":"27","author":"Link","year":"2001","journal-title":"Annu. Rev. Sociol."},{"issue":"Suppl. 5","key":"10.1016\/j.antiviral.2014.07.015_b0560","doi-asserted-by":"crossref","first-page":"S339","DOI":"10.1086\/427450","article-title":"Integrating services for injection drug users infected with hepatitis C virus with methadone maintenance treatment: challenges and opportunities","volume":"40","author":"Litwin","year":"2005","journal-title":"Clin. Infect. Dis."},{"issue":"1","key":"10.1016\/j.antiviral.2014.07.015_b0565","doi-asserted-by":"crossref","first-page":"46","DOI":"10.2105\/AJPH.91.1.46","article-title":"Prevalence and duration of hepatitis C among injection drug users in San Francisco","volume":"91","author":"Lorvick","year":"2001","journal-title":"Calif. Am J Public Health"},{"issue":"9775","key":"10.1016\/j.antiviral.2014.07.015_b0570","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1016\/S0140-6736(10)62353-7","article-title":"Reduction in overdose mortality after the opening of North America\u2019s first medically supervised safer injecting facility: a retrospective population-based study","volume":"377","author":"Marshall","year":"2011","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.antiviral.2014.07.015_b0575","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1521\/aeap.2014.26.2.144","article-title":"The Staying Safe Intervention: training people who inject drugs in strategies to avoid injection-related HCV and HIV Infection","volume":"26","author":"Mateu-Gelabert","year":"2014","journal-title":"AIDS Educ. Prev."},{"issue":"9651","key":"10.1016\/j.antiviral.2014.07.015_b0580","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1016\/S0140-6736(08)61311-2","article-title":"Global epidemiology of injecting drug use and HIV among people who inject drugs: a systematic review","volume":"372","author":"Mathers","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.antiviral.2014.07.015_b0585","unstructured":"Mauer M., 2003. Comparative International Rates of Incarceration: An Examination of Causes and Trends. Presentation to the U.S. Commission on Civil Rights. Sentencing Project, Washington DC. Accessed at <http:\/\/www.sentencingproject.org\/doc\/publications\/inc_comparative_intl.pdf> on 28 January 2014."},{"issue":"5","key":"10.1016\/j.antiviral.2014.07.015_b0590","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1111\/j.1365-2850.1996.tb00127.x","article-title":"An extended literature review of health professionals\u2019 perceptions of illicit drugs and their clients who use them","volume":"3","author":"McLaughlin","year":"1996","journal-title":"J. Psychiatr. Ment. Health Nurs."},{"issue":"13","key":"10.1016\/j.antiviral.2014.07.015_b0595","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1001\/jama.284.13.1689","article-title":"Drug dependence, a chronic medical illness: implications for treatment, insurance, and outcomes evaluation","volume":"284","author":"McLellan","year":"2000","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.antiviral.2014.07.015_b0600","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1007\/s11524-013-9807-x","article-title":"Increasing hepatitis C prevalence and associated risk behaviors among incarcerated young adults","volume":"91","author":"McNamara","year":"2013","journal-title":"J. Urban Health"},{"issue":"3","key":"10.1016\/j.antiviral.2014.07.015_b0605","doi-asserted-by":"crossref","first-page":"243","DOI":"10.7326\/0003-4819-136-3-200202050-00012","article-title":"Medical professionalism in the new millennium: a physician charter","volume":"136","author":"Medical Professionalism Project","year":"2002","journal-title":"Ann. Intern. Med."},{"issue":"5","key":"10.1016\/j.antiviral.2014.07.015_b0610","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1093\/infdis\/jiq112","article-title":"Changes in blood-borne infection risk among injection drug users","volume":"203","author":"Mehta","year":"2011","journal-title":"J. Infect. Dis."},{"issue":"5","key":"10.1016\/j.antiviral.2014.07.015_b0615","first-page":"327","article-title":"Mutual mistrust in the medical care of drug users: the keys to the \u201cnarc\u201d cabinet","volume":"17","author":"Merrill","year":"2002","journal-title":"J. Gen. Intern. Med."},{"year":"2011","series-title":"Drug Policy Profiles: Portugal","author":"Moreira","key":"10.1016\/j.antiviral.2014.07.015_b0620"},{"issue":"5","key":"10.1016\/j.antiviral.2014.07.015_b0625","doi-asserted-by":"crossref","first-page":"349","DOI":"10.7326\/0003-4819-159-5-201309030-00672","article-title":"Screening for hepatitis C virus infection in adults: U.S. Preventive Services Task Force recommendation statement","volume":"159","author":"Moyer","year":"2013","journal-title":"Ann. Intern. Med."},{"year":"1973","series-title":"The American Disease; Origins of Narcotic Control","author":"Musto","key":"10.1016\/j.antiviral.2014.07.015_b0630"},{"year":"2010","series-title":"Understanding the Demand for Illegal Drugs","author":"National Research Council","key":"10.1016\/j.antiviral.2014.07.015_b0635"},{"key":"10.1016\/j.antiviral.2014.07.015_b0640","unstructured":"Nazario S. The Children of the Drug Wars. New York Times 2014 July 13:SR1, SR6, SR 7."},{"issue":"9791","key":"10.1016\/j.antiviral.2014.07.015_b0645","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/S0140-6736(11)61097-0","article-title":"Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: results of systematic reviews","volume":"378","author":"Nelson","year":"2011","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.antiviral.2014.07.015_b0650","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.genhosppsych.2012.11.002","article-title":"Hepatitis C treatment and SVR: the gap between clinical trials and real-world treatment aspirations","volume":"35","author":"North","year":"2013","journal-title":"Gen. Hosp. Psychiatry"},{"year":"2013","series-title":"Hepatitis C Virus Infection in Young Persons Who Inject Drugs: Technical Consultation Report","author":"Office of HIV\/AIDS and Infectious Disease Policy","key":"10.1016\/j.antiviral.2014.07.015_b0655"},{"year":"2004","series-title":"The Price and Purity of Illicit Drugs","author":"Office of National Drug Control Policy","key":"10.1016\/j.antiviral.2014.07.015_b0660"},{"issue":"14","key":"10.1016\/j.antiviral.2014.07.015_b0665","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1001\/jama.2014.2147","article-title":"Confronting the stigma of opioid use disorder and its treatment","volume":"311","author":"Olsen","year":"2014","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.antiviral.2014.07.015_b0670","doi-asserted-by":"crossref","first-page":"i","DOI":"10.3310\/phr01040","article-title":"Community engagement to reduce inequalities in health: a systematic review, meta-analysis and economic analysis","volume":"1","author":"O\u2019Mara-Eves","year":"2013","journal-title":"Public Health Res."},{"issue":"8","key":"10.1016\/j.antiviral.2014.07.015_b0675","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1056\/NEJMoa0810635","article-title":"Diacetylmorphine versus methadone for the treatment of opioid addiction","volume":"361","author":"Oviedo-Joekes","year":"2009","journal-title":"N. Engl. J. Med."},{"issue":"8","key":"10.1016\/j.antiviral.2014.07.015_b0680","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1093\/infdis\/jit648","article-title":"Hepatitis C virus maintains infectivity for weeks after drying on inanimate surfaces at room temperature: implications for risks of transmission","volume":"209","author":"Paintsil","year":"2014","journal-title":"J. Infect. Dis."},{"issue":"5","key":"10.1016\/j.antiviral.2014.07.015_b0685","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1053\/j.gastro.2014.03.003","article-title":"New hepatitis C therapies: the toolbox, strategies, and challenges","volume":"146","author":"Pawlotsky","year":"2014","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.antiviral.2014.07.015_b0690","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.cld.2009.11.004","article-title":"US outbreak investigations highlight the need for safe injection practices and basic infection control","volume":"14","author":"Perz","year":"2010","journal-title":"Clin. Liver Dis."},{"year":"2003","series-title":"When Prisoners Come Home: Parole and Prisoner Reentry","author":"Petersilia","key":"10.1016\/j.antiviral.2014.07.015_b0695"},{"year":"2008","series-title":"Participation and the Right to the Highest Attainable Standard of Health","author":"Potts","key":"10.1016\/j.antiviral.2014.07.015_b0700"},{"year":"2013","series-title":"Blueprint for a Public Health and Safety Approach to Drug Policy","author":"Pugh","key":"10.1016\/j.antiviral.2014.07.015_b0710"},{"year":"1997","series-title":"Crack in America: Demon Drugs and Social Justice","author":"Reinarman","key":"10.1016\/j.antiviral.2014.07.015_b0715"},{"issue":"1","key":"10.1016\/j.antiviral.2014.07.015_b0720","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1093\/jurban\/jth092","article-title":"A syringe prescription program to prevent infectious disease and improve health of injection drug users","volume":"81","author":"Rich","year":"2004","journal-title":"J. Urban Health"},{"issue":"3","key":"10.1016\/j.antiviral.2014.07.015_b0725","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1377\/hlthaff.2013.1133","article-title":"How health care reform can transform the health of criminal justice-involved individuals","volume":"33","author":"Rich","year":"2014","journal-title":"Health Aff. (Millwood)"},{"issue":"20","key":"10.1016\/j.antiviral.2014.07.015_b0730","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1056\/NEJMp1311941","article-title":"Responding to hepatitis C through the criminal justice system","volume":"370","author":"Rich","year":"2014","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.antiviral.2014.07.015_b0735","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1080\/09595230500102434","article-title":"Stigma, social inequality and alcohol and drug use","volume":"24","author":"Room","year":"2005","journal-title":"Drug Alcohol Rev."},{"issue":"Suppl. 3","key":"10.1016\/j.antiviral.2014.07.015_b0740","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1177\/00333549131286S303","article-title":"What can public health programs do to improve health equity?","volume":"128","author":"Sadana","year":"2013","journal-title":"Public Health Rep."},{"year":"2011","series-title":"Law Enforcement Assisted Diversion Program","author":"Satterberg","key":"10.1016\/j.antiviral.2014.07.015_b0745"},{"issue":"4","key":"10.1016\/j.antiviral.2014.07.015_b0750","article-title":"Seattle LEAD\u2019s on Law Enforcement Diversion","volume":"6","author":"Satterberg","year":"2013","journal-title":"Community Policing Dispatch"},{"year":"2012","series-title":"Drug Consumption Rooms: Evidence and Practice","author":"Schatz","key":"10.1016\/j.antiviral.2014.07.015_b0755"},{"issue":"1","key":"10.1016\/j.antiviral.2014.07.015_b0760","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1477-7517-9-17","article-title":"Harmonizing disease prevention and police practice in the implementation of HIV prevention programs: up-stream strategies from Wilmington, Delaware","volume":"9","author":"Silverman","year":"2012","journal-title":"Harm Reduct. J."},{"issue":"2","key":"10.1016\/j.antiviral.2014.07.015_b0765","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.drugpo.2007.09.002","article-title":"Injecting drug users: a stigmatised and stigmatising population","volume":"20","author":"Simmonds","year":"2009","journal-title":"Int. J. Drug Policy"},{"issue":"RR-4","key":"10.1016\/j.antiviral.2014.07.015_b0770","first-page":"1","article-title":"Recommendations for the identification of chronic hepatitis C virus infection among persons born during 1945\u20131965","volume":"61","author":"Smith","year":"2012","journal-title":"MMWR Recomm. Rep."},{"issue":"10","key":"10.1016\/j.antiviral.2014.07.015_b0775","doi-asserted-by":"crossref","first-page":"762","DOI":"10.7326\/0003-4819-144-10-200605160-00010","article-title":"A framework for management of hepatitis C in prisons","volume":"144","author":"Spaulding","year":"2006","journal-title":"Ann. Intern. Med."},{"issue":"2","key":"10.1016\/j.antiviral.2014.07.015_b0780","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1300\/J034v04n02_13","article-title":"Effective AIDS prevention with active drug users: the harm reduction model","volume":"4","author":"Springer","year":"1992","journal-title":"J. Chem. Depend. Treat."},{"issue":"3","key":"10.1016\/j.antiviral.2014.07.015_b0785","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1002\/hep.24131","article-title":"Insurance status and treatment candidacy of hepatitis C patients: analysis of population-based data from the United States","volume":"53","author":"Stepanova","year":"2011","journal-title":"Hepatology"},{"year":"2012","series-title":"The Price of Inequality: How Today\u2019s Divided Society Endangers our Future","author":"Stiglitz","key":"10.1016\/j.antiviral.2014.07.015_b0790"},{"year":"2012","series-title":"New Heroin-Assisted Treatment: Recent Evidence and Current Practices of Supervised Injectable Heroin Treatment in Europe and Beyond","author":"Strang","key":"10.1016\/j.antiviral.2014.07.015_b0795"},{"year":"2013","series-title":"Best Practice Recommendations for Canadian Harm Reduction Programs that Provide Service to People Who Use Drugs and Are at Risk for HIV, HCV and Other Harms: Part 1","author":"Strike","key":"10.1016\/j.antiviral.2014.07.015_b0800"},{"year":"2013","series-title":"Sentencing and Prison Practices in Germany and the Netherlands: Implications for the United States","author":"Subramanian","key":"10.1016\/j.antiviral.2014.07.015_b0805"},{"key":"10.1016\/j.antiviral.2014.07.015_b0810","unstructured":"Substance Abuse and Mental Health Services Administration, 2013. Results from the 2012 National Survey on Drug Use and Health: Summary of national findings. NSDUH Series H-46, HHS Publication No. (SMA) 13-4795. US Department of Health and Human Services, Rockville, MD. Accessed at <http:\/\/www.samhsa.gov\/data\/NSDUH\/2012SummNatFindDetTables\/Index.aspx> on 4 April 2014."},{"issue":"6","key":"10.1016\/j.antiviral.2014.07.015_b0815","doi-asserted-by":"crossref","first-page":"e64789","DOI":"10.1371\/journal.pone.0064789","article-title":"Trends in the population prevalence of people who inject drugs in US metropolitan areas 1992\u20132007","volume":"8","author":"Tempalski","year":"2013","journal-title":"PLoS ONE"},{"year":"2008","series-title":"Hepatitis C Action Plan for Scotland: Phase II: May 2008\u2013March 2011","author":"The Scottish Government","key":"10.1016\/j.antiviral.2014.07.015_b0820"},{"issue":"7","key":"10.1016\/j.antiviral.2014.07.015_b0825","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1038\/nm.3184","article-title":"Global control of hepatitis C: where challenge meets opportunity","volume":"19","author":"Thomas","year":"2013","journal-title":"Nat. Med."},{"year":"2008","series-title":"Releasing Prisoners, Redeeming Communities: Reentry, Race, and Politics","author":"Thompson","key":"10.1016\/j.antiviral.2014.07.015_b0830"},{"issue":"1","key":"10.1016\/j.antiviral.2014.07.015_b0835","doi-asserted-by":"crossref","first-page":"33","DOI":"10.7326\/0003-4819-150-1-200901060-00007","article-title":"Nonhospital health care-associated hepatitis B and C virus transmission: United States, 1998\u20132008","volume":"150","author":"Thompson","year":"2009","journal-title":"Ann. Intern. Med."},{"issue":"7","key":"10.1016\/j.antiviral.2014.07.015_b0840","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1093\/aje\/155.7.645","article-title":"Risk of hepatitis C virus infection among young adult injection drug users who share injection equipment","volume":"155","author":"Thorpe","year":"2002","journal-title":"Am. J. Epidemiol."},{"year":"2013","series-title":"Judging Addicts: Drug Courts and Coercion in the Justice System","author":"Tiger","key":"10.1016\/j.antiviral.2014.07.015_b0845"},{"year":"2014","series-title":"National Research Council (U.S.). Committee on Law and Justice. The Growth of Incarceration in the United States: Exploring Causes and Consequences","author":"Travis","key":"10.1016\/j.antiviral.2014.07.015_b0850"},{"issue":"3","key":"10.1016\/j.antiviral.2014.07.015_b0855","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1002\/hep.21765","article-title":"Seroprevalence of hepatitis C virus and hepatitis B virus among San Francisco injection drug users, 1998 to 2000","volume":"46","author":"Tseng","year":"2007","journal-title":"Hepatology"},{"year":"2013","series-title":"A Living Death: Life without Parole for Nonviolent Offenses","author":"Turner","key":"10.1016\/j.antiviral.2014.07.015_b0860"},{"key":"10.1016\/j.antiviral.2014.07.015_b0865","unstructured":"U.S. Department of Health and Human Services, 2014. Combating the Silent Epidemic of Viral Hepatitis: Action Plan for the Prevention, Care & Treatment of Viral Hepatitis. Updated 2014\u20132016. Accessed at <http:\/\/aids.gov\/news-and-events\/hepatitis\/> on 12 April 2014."},{"key":"10.1016\/j.antiviral.2014.07.015_b0870","unstructured":"UN Economic and Social Council, 2000. The Right to the Highest Attainable Standard of Health, General Comment No. 14. E\/C.12\/2000\/4. Office of the United Nations High Commissioner for Human Rights, Geneva. Accessed at <http:\/\/www.unhchr.ch\/tbs\/doc.nsf\/(symbol)\/E.C.12.2000.4.En> on 3 February 2014."},{"year":"2009","series-title":"World Drug Report 2009","author":"United Nations Office on Drugs and Crime (UNODC)","key":"10.1016\/j.antiviral.2014.07.015_b0875"},{"year":"2005","series-title":"2005 World drug report","author":"United Nations Office on Drugs and Crime","key":"10.1016\/j.antiviral.2014.07.015_b0880"},{"year":"2008","series-title":"Reducing the Adverse Health and Social Consequences of Drug Abuse: A comprehensive Approach","author":"United Nations Office on Drugs and Crime","key":"10.1016\/j.antiviral.2014.07.015_b0885"},{"year":"2013","series-title":"Police Leadership in Harm Reduction and the HIV Response","author":"United Nations Office on Drugs and Crime","key":"10.1016\/j.antiviral.2014.07.015_b0890"},{"year":"2006","series-title":"International Guidelines on HIV\/AIDS and Human Rights 2006","author":"United Nations Programme on HIV\/AIDS (UNAIDS)","key":"10.1016\/j.antiviral.2014.07.015_b0895"},{"issue":"1\u20132","key":"10.1016\/j.antiviral.2014.07.015_b0900","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.drugalcdep.2013.02.018","article-title":"Stigma among health professionals towards patients with substance use disorders and its consequences for healthcare delivery: systematic review","volume":"131","author":"van Boekel","year":"2013","journal-title":"Drug Alcohol Depend."},{"issue":"9","key":"10.1016\/j.antiviral.2014.07.015_b0905","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1111\/j.1360-0443.2007.01912.x","article-title":"Full participation in harm reduction programmes is associated with decreased risk for human immunodeficiency virus and hepatitis C virus: evidence from the Amsterdam Cohort Studies among drug users","volume":"102","author":"Van Den Berg","year":"2007","journal-title":"Addiction"},{"year":"2011","series-title":"Addicted to Courts: How a Growing Dependence on Drug Courts Impacts People and Communities","author":"Walsh","key":"10.1016\/j.antiviral.2014.07.015_b0910"},{"key":"10.1016\/j.antiviral.2014.07.015_b0915","unstructured":"World Health Organization, 1986. Ottawa Charter for Health Promotion. Accessed at <http:\/\/www.who.int\/healthpromotion\/conferences\/previous\/ottawa\/en\/> on 8 January 2014."},{"issue":"2","key":"10.1016\/j.antiviral.2014.07.015_b0920","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1353\/foc.2010.0006","article-title":"Incarceration in fragile families","volume":"20","author":"Wildeman","year":"2010","journal-title":"Future Child."},{"issue":"9668","key":"10.1016\/j.antiviral.2014.07.015_b0925","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/S0140-6736(09)60455-4","article-title":"The war on drugs: a devastating public-policy disaster","volume":"373","author":"Wood","year":"2009","journal-title":"Lancet"},{"issue":"9738","key":"10.1016\/j.antiviral.2014.07.015_b0930","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/S0140-6736(10)60958-0","article-title":"Vienna Declaration: a call for evidence-based drug policies","volume":"376","author":"Wood","year":"2010","journal-title":"Lancet"},{"year":"1946","series-title":"Constitution of the World Health Organization","author":"World Health Organization","key":"10.1016\/j.antiviral.2014.07.015_b0935"},{"year":"2007","series-title":"Guide to Starting and Managing Needle and Syringe Programmes","author":"World Health Organization","key":"10.1016\/j.antiviral.2014.07.015_b0940"},{"year":"2012","series-title":"Guidance on Prevention of Viral Hepatitis B And C Among People Who Inject Drugs","author":"World Health Organization","key":"10.1016\/j.antiviral.2014.07.015_b0945"},{"year":"2008","series-title":"Closing the Gap in a Generation: Health Equity through Action on the Social Determinants of Health: Commission on Social Determinants of Health Final Report","author":"World Health Organization Commission on Social Determinants of Health","key":"10.1016\/j.antiviral.2014.07.015_b0950"},{"issue":"7","key":"10.1016\/j.antiviral.2014.07.015_b0955","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1136\/sextrans-2012-050566","article-title":"Incidence of acute hepatitis C virus infection among men who have sex with men with and without HIV infection: a systematic review","volume":"88","author":"Yaphe","year":"2012","journal-title":"Sex. Transm. Infect."},{"issue":"1","key":"10.1016\/j.antiviral.2014.07.015_b0960","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.drugpo.2012.07.002","article-title":"Are major reductions in new HIV infections possible with people who inject drugs? The case for low dead-space syringes in highly affected countries","volume":"24","author":"Zule","year":"2013","journal-title":"Int. J. Drug Policy"}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354214002149?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354214002149?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,10,30]],"date-time":"2019-10-30T07:55:38Z","timestamp":1572422138000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354214002149"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10]]},"references-count":192,"alternative-id":["S0166354214002149"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2014.07.015","relation":{},"ISSN":["0166-3542"],"issn-type":[{"type":"print","value":"0166-3542"}],"subject":[],"published":{"date-parts":[[2014,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Can hepatitis C be eradicated in the United States?","name":"articletitle","label":"Article Title"},{"value":"Antiviral Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.antiviral.2014.07.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}